A randomized trial evaluating the association between related gene polymorphism and nausea and vomiting induced by cisplatin multi-day chemotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized trial evaluating the association between related gene polymorphism and nausea and vomiting induced by cisplatin multi-day chemotherapy
Authors
Keywords
-
Journal
BMC Medical Genomics
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1186/s12920-023-01719-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
- (2021) Yilan Jin et al. Pharmacogenomics & Personalized Medicine
- Effect of the allelic variants ofABCB1, CYP2D6andHTR3Bon response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients
- (2016) Gaeun Kang et al. Asia-Pacific Journal of Clinical Oncology
- An Analysis of Behavioral and Genetic Risk Factors for Chemotherapy-Induced Nausea and Vomiting in Japanese Subjects
- (2016) Naoki Mukoyama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study
- (2016) D Tsuji et al. PHARMACOGENOMICS JOURNAL
- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer
- (2014) Dorit Pud et al. BREAST CANCER RESEARCH AND TREATMENT
- DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147)
- (2014) Adam M. Lee et al. JNCI-Journal of the National Cancer Institute
- Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer
- (2014) Jatinder Kaur Lamba et al. PHARMACOGENOMICS
- Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis
- (2013) Ikuo Sekine et al. CANCER SCIENCE
- Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study
- (2013) Amalia S Lehmann et al. BMC Pregnancy and Childbirth
- A first step towards the understanding of the 5-HT3 receptor subunit heterogeneity from a computational point of view
- (2012) Francesca De Rienzo et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Association of ABCB1, 5-HT3B Receptor and CYP2D6 Genetic Polymorphisms with Ondansetron and Metoclopramide Antiemetic Response in Indonesian Cancer Patients Treated with Highly Emetogenic Chemotherapy
- (2011) D. A. Perwitasari et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
- (2011) H E Wheeler et al. PHARMACOGENOMICS JOURNAL
- Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron
- (2010) M V Tzvetkov et al. PHARMACOGENOMICS JOURNAL
- First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome
- (2008) Johannes Kapeller et al. HUMAN MOLECULAR GENETICS
- Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy
- (2008) P. A. Fasching et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The 5-HT3 receptor – the relationship between structure and function
- (2008) Nicholas M. Barnes et al. NEUROPHARMACOLOGY
- Investigation ofHTR3Cmutations for association with 5HT3receptor antagonist anti-emetic efficacy
- (2008) Michael B Ward et al. PHARMACOGENOMICS
- Serotonin type 3 receptor genes:HTR3A, B, C, D, E
- (2008) Beate Niesler et al. PHARMACOGENOMICS
- High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor
- (2008) K. Krzywkowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started